Have questions for our experts or want more information?
Contact Us Today
Webinar Overview
Autoimmune and allergic diseases remain amongst the most complex to treat, but with the help of advanced translational models and primary human assays, you now have better predictive tools to find and develop the most impactful candidates to get to patients who need them.
This webinar explores how CAR-T, B cell-depleting therapies, and mast cell-targeted approaches are reshaping the future of treatment and, more importantly, how it will influence your drug discovery strategies. Whether you’re advancing a new candidate or exploring drug repurposing opportunities, this session delivers insights to help you stay ahead and drive the future of immunology drug discovery.
You will discover:
- How predictive models reduce risk and help prioritize drug candidates
- The impacts of B-cell depletion and CAR-T approaches on autoimmune disease pipelines
- Mast cell-modulating strategies and their influence on the future of allergic disease
Webinar Presenters
Lorena Sueiro Ballesteros, MRes
Group Leader, In Vitro Biology
Charles River
Lisa Scandiuzzi, PhD
Associate Research Leader, NL Discovery Sciences
Charles River